Gene Therapy for Parkinson’s Disease by Innervate Therapeutics for Parkinson’s Disease: Likelihood of Approval
Pharmaceutical Technology
MAY 17, 2024
Gene Therapy for Parkinson’s Disease is under clinical development by Innervate Therapeutics and currently in Phase II for Parkinson's Disease.
Let's personalize your content